Fitxers

899235.pdf (636.96 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2025-08-21

Llicència de publicació

cc-by (c) Martín-Escolano, J. et al., 2025
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/223363

Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1371/journal.pone.0330495

Resum

Objectives: SARS-CoV-2 RNAemia at diagnosis is associated with mortality. The aims were to identify factors associated with the development of RNAemia. Methods: Multicenter COVID-19 cohort study was conducted between January 2020 and May 2023. Demographics, chronic underlying diseases, symptoms and signs, analytical and radiological variables, cytokines, and neutralizing antibodies were evaluated on admission. RNAemia was the primary endpoint. Results: We included 1011 patients, 392 (38.8%) immunocompromised and 619 (61.2%) immunocompetent. RNAemia occurred in 49.7% and 18.7% (p < 0.001), respectively, being independently associated with 30-day all-cause mortality. In immunocompromised patients, factors independently associated with RNAemia were Alpha and Omicron VOC periods (OR: 1.95 [1.01-3.79]), pneumonia (OR: 1.96 [1.10-3.50]), LDH > 300 UI/L (OR: 1.64 [1.02-2.63]) and neutralizing antibodies absence (OR: 2.51 [1.57-4.00]). In immunocompetent patients, the factors associated with RNAemia were Delta and Omicron VOC periods (OR: 2.27 [1.46-3.52]), lymphocyte count < 1000/µL (OR: 1.81 [1.16-2.80]) and LDH levels > 300 IU/L (OR: 3.99 [2.51-6.36]). Conclusions: Immunodeficiency almost tripled SARS-CoV-2 RNAemia. Omicron VOC period, LDH as inflammatory biomarker, and a lower immune response in all patients, neutralizing antibodies absence in immunocompromised and lymphopenia in immunocompetent, and pneumonia in immunocompromised patients were associated with RNAemia.

Matèries

Adults, COVID-19, Anticossos policlonals

Matèries (anglès)

Adulthood, COVID-19, Polyclonal antibodies

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

MARTÍN-ESCOLANO, Javier, et al. Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis. PLoS One. 2025. Vol. 20, num. 8. ISSN 1932-6203. [consulted: 24 of May of 2026]. Available at: https://hdl.handle.net/2445/223363

Exportar metadades

JSON - METS

Compartir registre